Management of cystic echinococcosis in the last two decades: what have we learned?
Management options for cystic echinococcosis (CE) remain a serious problem. The main aim of this study was to examine the selection and complications of treatment applied in patients with CE. The second aim was to evaluate the mortality rate and causative factors. A retrospective descriptive study o...
Gespeichert in:
Veröffentlicht in: | Transactions of the Royal Society of Tropical Medicine and Hygiene 2018-05, Vol.112 (5), p.207-215 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 215 |
---|---|
container_issue | 5 |
container_start_page | 207 |
container_title | Transactions of the Royal Society of Tropical Medicine and Hygiene |
container_volume | 112 |
creator | Velasco-Tirado, Virginia Romero-Alegria, Angela Pardo-Lledías, Javier Alonso-Sardón, Montserrat Lopez-Bernus, Amparo Sampedro, Jose Quiñones Bellvis, Luis Muñoz Iglesias Gomez, Alicia Muro, Antonio Muñoz Bellido, Juan Luis Iglesias-Iglesias, Manuel Jimenez Lopez, Marcelo Fernando Belhassen-García, Moncef |
description | Management options for cystic echinococcosis (CE) remain a serious problem. The main aim of this study was to examine the selection and complications of treatment applied in patients with CE. The second aim was to evaluate the mortality rate and causative factors.
A retrospective descriptive study of patients diagnosed with CE between 1998 and 2015 was conducted, according to ICD-9 (code 122·0 to 122·9) criteria in the Complejo Asistencial Universitario of Salamanca, Spain.
Four-hundred-ninety-one (491) patients were diagnosed with CE disease and the treatment applied in these patients were: 166 (33.8%) patients received only surgery, 176 (35.8%) surgery and drugs, 17 (3.5%) drugs alone, in 131 (26.7%) patients the strategy was 'watch and wait', and only one patient (0.2%) was applied puncture-aspiration-injection-respiration (PAIR). Thus, a total of 342 patients received surgery, either alone (166) or combined with drugs (176), and a total of 193 (39.4%) patients were medically treated, either alone (17) or combined with surgery (176); 123 (63.7%) patients used albendazole alone; and 70 (36.3%) patients used a combination of albendazole and praziquantel. Sixty-five patients (19.0%) had complications after surgery and seven of them (2%) died. Only 15 (7.8%) cases had side effects from anthelmintics. Throughout the study period, 80 (16.3%) patients died, 14 (2.9%) of them due to CE disease.
Complications of CE are one of the most common causes of mortality in CE patients, with size, location, and number of cysts, and the 'watch and wait' treatment strategy being the main factors associated with mortality. |
doi_str_mv | 10.1093/trstmh/try050 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2054942522</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2054942522</sourcerecordid><originalsourceid>FETCH-LOGICAL-c332t-e5372727303d4f526f660b53c7295214a48e523ac057e4138d487b1869b5b3973</originalsourceid><addsrcrecordid>eNo9kE1LxDAURYMozji6dCtZuqkmeX1t40Zk8AtGBNF1SdNXW2mbsck4zL-3UpW7uIt7uIvD2KkUF1JouAyDD1091k6g2GNzmaVZBChgn82FAIy0EjBjR95_CKFQoj5kM6UznSKqOXt5Mr15p476wF3F7c6HxnKyddM766x1vvG86XmoibfGBx62jpdkTUn-im9rE3htvohvx5nM0FN5fcwOKtN6OvntBXu7u31dPkSr5_vH5c0qsgAqRISQqjEgoIwrVEmVJKJAsKnSqGRs4oxQgbECU4olZGWcpYXMEl1gATqFBTuffteD-9yQD3nXeEtta3pyG58rgbGOFSo1otGE2sF5P1CVr4emM8MulyL_0ZhPGvNJ48if_V5vio7Kf_rPG3wD8B1uwQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2054942522</pqid></control><display><type>article</type><title>Management of cystic echinococcosis in the last two decades: what have we learned?</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Velasco-Tirado, Virginia ; Romero-Alegria, Angela ; Pardo-Lledías, Javier ; Alonso-Sardón, Montserrat ; Lopez-Bernus, Amparo ; Sampedro, Jose Quiñones ; Bellvis, Luis Muñoz ; Iglesias Gomez, Alicia ; Muro, Antonio ; Muñoz Bellido, Juan Luis ; Iglesias-Iglesias, Manuel ; Jimenez Lopez, Marcelo Fernando ; Belhassen-García, Moncef</creator><creatorcontrib>Velasco-Tirado, Virginia ; Romero-Alegria, Angela ; Pardo-Lledías, Javier ; Alonso-Sardón, Montserrat ; Lopez-Bernus, Amparo ; Sampedro, Jose Quiñones ; Bellvis, Luis Muñoz ; Iglesias Gomez, Alicia ; Muro, Antonio ; Muñoz Bellido, Juan Luis ; Iglesias-Iglesias, Manuel ; Jimenez Lopez, Marcelo Fernando ; Belhassen-García, Moncef</creatorcontrib><description>Management options for cystic echinococcosis (CE) remain a serious problem. The main aim of this study was to examine the selection and complications of treatment applied in patients with CE. The second aim was to evaluate the mortality rate and causative factors.
A retrospective descriptive study of patients diagnosed with CE between 1998 and 2015 was conducted, according to ICD-9 (code 122·0 to 122·9) criteria in the Complejo Asistencial Universitario of Salamanca, Spain.
Four-hundred-ninety-one (491) patients were diagnosed with CE disease and the treatment applied in these patients were: 166 (33.8%) patients received only surgery, 176 (35.8%) surgery and drugs, 17 (3.5%) drugs alone, in 131 (26.7%) patients the strategy was 'watch and wait', and only one patient (0.2%) was applied puncture-aspiration-injection-respiration (PAIR). Thus, a total of 342 patients received surgery, either alone (166) or combined with drugs (176), and a total of 193 (39.4%) patients were medically treated, either alone (17) or combined with surgery (176); 123 (63.7%) patients used albendazole alone; and 70 (36.3%) patients used a combination of albendazole and praziquantel. Sixty-five patients (19.0%) had complications after surgery and seven of them (2%) died. Only 15 (7.8%) cases had side effects from anthelmintics. Throughout the study period, 80 (16.3%) patients died, 14 (2.9%) of them due to CE disease.
Complications of CE are one of the most common causes of mortality in CE patients, with size, location, and number of cysts, and the 'watch and wait' treatment strategy being the main factors associated with mortality.</description><identifier>ISSN: 0035-9203</identifier><identifier>EISSN: 1878-3503</identifier><identifier>DOI: 10.1093/trstmh/try050</identifier><identifier>PMID: 29897552</identifier><language>eng</language><publisher>England</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Albendazole - therapeutic use ; Animals ; Anthelmintics - therapeutic use ; Clinical Protocols ; Combined Modality Therapy - methods ; Combined Modality Therapy - mortality ; Cysts - parasitology ; Cysts - therapy ; Drug Therapy, Combination ; Echinococcosis - mortality ; Echinococcosis - therapy ; Female ; Humans ; Longitudinal Studies ; Male ; Middle Aged ; Praziquantel - therapeutic use ; Retrospective Studies ; Spain - epidemiology ; Treatment Outcome ; Watchful Waiting</subject><ispartof>Transactions of the Royal Society of Tropical Medicine and Hygiene, 2018-05, Vol.112 (5), p.207-215</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c332t-e5372727303d4f526f660b53c7295214a48e523ac057e4138d487b1869b5b3973</citedby><cites>FETCH-LOGICAL-c332t-e5372727303d4f526f660b53c7295214a48e523ac057e4138d487b1869b5b3973</cites><orcidid>0000-0002-2230-1256</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29897552$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Velasco-Tirado, Virginia</creatorcontrib><creatorcontrib>Romero-Alegria, Angela</creatorcontrib><creatorcontrib>Pardo-Lledías, Javier</creatorcontrib><creatorcontrib>Alonso-Sardón, Montserrat</creatorcontrib><creatorcontrib>Lopez-Bernus, Amparo</creatorcontrib><creatorcontrib>Sampedro, Jose Quiñones</creatorcontrib><creatorcontrib>Bellvis, Luis Muñoz</creatorcontrib><creatorcontrib>Iglesias Gomez, Alicia</creatorcontrib><creatorcontrib>Muro, Antonio</creatorcontrib><creatorcontrib>Muñoz Bellido, Juan Luis</creatorcontrib><creatorcontrib>Iglesias-Iglesias, Manuel</creatorcontrib><creatorcontrib>Jimenez Lopez, Marcelo Fernando</creatorcontrib><creatorcontrib>Belhassen-García, Moncef</creatorcontrib><title>Management of cystic echinococcosis in the last two decades: what have we learned?</title><title>Transactions of the Royal Society of Tropical Medicine and Hygiene</title><addtitle>Trans R Soc Trop Med Hyg</addtitle><description>Management options for cystic echinococcosis (CE) remain a serious problem. The main aim of this study was to examine the selection and complications of treatment applied in patients with CE. The second aim was to evaluate the mortality rate and causative factors.
A retrospective descriptive study of patients diagnosed with CE between 1998 and 2015 was conducted, according to ICD-9 (code 122·0 to 122·9) criteria in the Complejo Asistencial Universitario of Salamanca, Spain.
Four-hundred-ninety-one (491) patients were diagnosed with CE disease and the treatment applied in these patients were: 166 (33.8%) patients received only surgery, 176 (35.8%) surgery and drugs, 17 (3.5%) drugs alone, in 131 (26.7%) patients the strategy was 'watch and wait', and only one patient (0.2%) was applied puncture-aspiration-injection-respiration (PAIR). Thus, a total of 342 patients received surgery, either alone (166) or combined with drugs (176), and a total of 193 (39.4%) patients were medically treated, either alone (17) or combined with surgery (176); 123 (63.7%) patients used albendazole alone; and 70 (36.3%) patients used a combination of albendazole and praziquantel. Sixty-five patients (19.0%) had complications after surgery and seven of them (2%) died. Only 15 (7.8%) cases had side effects from anthelmintics. Throughout the study period, 80 (16.3%) patients died, 14 (2.9%) of them due to CE disease.
Complications of CE are one of the most common causes of mortality in CE patients, with size, location, and number of cysts, and the 'watch and wait' treatment strategy being the main factors associated with mortality.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Albendazole - therapeutic use</subject><subject>Animals</subject><subject>Anthelmintics - therapeutic use</subject><subject>Clinical Protocols</subject><subject>Combined Modality Therapy - methods</subject><subject>Combined Modality Therapy - mortality</subject><subject>Cysts - parasitology</subject><subject>Cysts - therapy</subject><subject>Drug Therapy, Combination</subject><subject>Echinococcosis - mortality</subject><subject>Echinococcosis - therapy</subject><subject>Female</subject><subject>Humans</subject><subject>Longitudinal Studies</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Praziquantel - therapeutic use</subject><subject>Retrospective Studies</subject><subject>Spain - epidemiology</subject><subject>Treatment Outcome</subject><subject>Watchful Waiting</subject><issn>0035-9203</issn><issn>1878-3503</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kE1LxDAURYMozji6dCtZuqkmeX1t40Zk8AtGBNF1SdNXW2mbsck4zL-3UpW7uIt7uIvD2KkUF1JouAyDD1091k6g2GNzmaVZBChgn82FAIy0EjBjR95_CKFQoj5kM6UznSKqOXt5Mr15p476wF3F7c6HxnKyddM766x1vvG86XmoibfGBx62jpdkTUn-im9rE3htvohvx5nM0FN5fcwOKtN6OvntBXu7u31dPkSr5_vH5c0qsgAqRISQqjEgoIwrVEmVJKJAsKnSqGRs4oxQgbECU4olZGWcpYXMEl1gATqFBTuffteD-9yQD3nXeEtta3pyG58rgbGOFSo1otGE2sF5P1CVr4emM8MulyL_0ZhPGvNJ48if_V5vio7Kf_rPG3wD8B1uwQ</recordid><startdate>20180501</startdate><enddate>20180501</enddate><creator>Velasco-Tirado, Virginia</creator><creator>Romero-Alegria, Angela</creator><creator>Pardo-Lledías, Javier</creator><creator>Alonso-Sardón, Montserrat</creator><creator>Lopez-Bernus, Amparo</creator><creator>Sampedro, Jose Quiñones</creator><creator>Bellvis, Luis Muñoz</creator><creator>Iglesias Gomez, Alicia</creator><creator>Muro, Antonio</creator><creator>Muñoz Bellido, Juan Luis</creator><creator>Iglesias-Iglesias, Manuel</creator><creator>Jimenez Lopez, Marcelo Fernando</creator><creator>Belhassen-García, Moncef</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-2230-1256</orcidid></search><sort><creationdate>20180501</creationdate><title>Management of cystic echinococcosis in the last two decades: what have we learned?</title><author>Velasco-Tirado, Virginia ; Romero-Alegria, Angela ; Pardo-Lledías, Javier ; Alonso-Sardón, Montserrat ; Lopez-Bernus, Amparo ; Sampedro, Jose Quiñones ; Bellvis, Luis Muñoz ; Iglesias Gomez, Alicia ; Muro, Antonio ; Muñoz Bellido, Juan Luis ; Iglesias-Iglesias, Manuel ; Jimenez Lopez, Marcelo Fernando ; Belhassen-García, Moncef</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c332t-e5372727303d4f526f660b53c7295214a48e523ac057e4138d487b1869b5b3973</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Albendazole - therapeutic use</topic><topic>Animals</topic><topic>Anthelmintics - therapeutic use</topic><topic>Clinical Protocols</topic><topic>Combined Modality Therapy - methods</topic><topic>Combined Modality Therapy - mortality</topic><topic>Cysts - parasitology</topic><topic>Cysts - therapy</topic><topic>Drug Therapy, Combination</topic><topic>Echinococcosis - mortality</topic><topic>Echinococcosis - therapy</topic><topic>Female</topic><topic>Humans</topic><topic>Longitudinal Studies</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Praziquantel - therapeutic use</topic><topic>Retrospective Studies</topic><topic>Spain - epidemiology</topic><topic>Treatment Outcome</topic><topic>Watchful Waiting</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Velasco-Tirado, Virginia</creatorcontrib><creatorcontrib>Romero-Alegria, Angela</creatorcontrib><creatorcontrib>Pardo-Lledías, Javier</creatorcontrib><creatorcontrib>Alonso-Sardón, Montserrat</creatorcontrib><creatorcontrib>Lopez-Bernus, Amparo</creatorcontrib><creatorcontrib>Sampedro, Jose Quiñones</creatorcontrib><creatorcontrib>Bellvis, Luis Muñoz</creatorcontrib><creatorcontrib>Iglesias Gomez, Alicia</creatorcontrib><creatorcontrib>Muro, Antonio</creatorcontrib><creatorcontrib>Muñoz Bellido, Juan Luis</creatorcontrib><creatorcontrib>Iglesias-Iglesias, Manuel</creatorcontrib><creatorcontrib>Jimenez Lopez, Marcelo Fernando</creatorcontrib><creatorcontrib>Belhassen-García, Moncef</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Transactions of the Royal Society of Tropical Medicine and Hygiene</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Velasco-Tirado, Virginia</au><au>Romero-Alegria, Angela</au><au>Pardo-Lledías, Javier</au><au>Alonso-Sardón, Montserrat</au><au>Lopez-Bernus, Amparo</au><au>Sampedro, Jose Quiñones</au><au>Bellvis, Luis Muñoz</au><au>Iglesias Gomez, Alicia</au><au>Muro, Antonio</au><au>Muñoz Bellido, Juan Luis</au><au>Iglesias-Iglesias, Manuel</au><au>Jimenez Lopez, Marcelo Fernando</au><au>Belhassen-García, Moncef</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Management of cystic echinococcosis in the last two decades: what have we learned?</atitle><jtitle>Transactions of the Royal Society of Tropical Medicine and Hygiene</jtitle><addtitle>Trans R Soc Trop Med Hyg</addtitle><date>2018-05-01</date><risdate>2018</risdate><volume>112</volume><issue>5</issue><spage>207</spage><epage>215</epage><pages>207-215</pages><issn>0035-9203</issn><eissn>1878-3503</eissn><abstract>Management options for cystic echinococcosis (CE) remain a serious problem. The main aim of this study was to examine the selection and complications of treatment applied in patients with CE. The second aim was to evaluate the mortality rate and causative factors.
A retrospective descriptive study of patients diagnosed with CE between 1998 and 2015 was conducted, according to ICD-9 (code 122·0 to 122·9) criteria in the Complejo Asistencial Universitario of Salamanca, Spain.
Four-hundred-ninety-one (491) patients were diagnosed with CE disease and the treatment applied in these patients were: 166 (33.8%) patients received only surgery, 176 (35.8%) surgery and drugs, 17 (3.5%) drugs alone, in 131 (26.7%) patients the strategy was 'watch and wait', and only one patient (0.2%) was applied puncture-aspiration-injection-respiration (PAIR). Thus, a total of 342 patients received surgery, either alone (166) or combined with drugs (176), and a total of 193 (39.4%) patients were medically treated, either alone (17) or combined with surgery (176); 123 (63.7%) patients used albendazole alone; and 70 (36.3%) patients used a combination of albendazole and praziquantel. Sixty-five patients (19.0%) had complications after surgery and seven of them (2%) died. Only 15 (7.8%) cases had side effects from anthelmintics. Throughout the study period, 80 (16.3%) patients died, 14 (2.9%) of them due to CE disease.
Complications of CE are one of the most common causes of mortality in CE patients, with size, location, and number of cysts, and the 'watch and wait' treatment strategy being the main factors associated with mortality.</abstract><cop>England</cop><pmid>29897552</pmid><doi>10.1093/trstmh/try050</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-2230-1256</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0035-9203 |
ispartof | Transactions of the Royal Society of Tropical Medicine and Hygiene, 2018-05, Vol.112 (5), p.207-215 |
issn | 0035-9203 1878-3503 |
language | eng |
recordid | cdi_proquest_miscellaneous_2054942522 |
source | Oxford University Press Journals All Titles (1996-Current); MEDLINE; Alma/SFX Local Collection |
subjects | Adult Aged Aged, 80 and over Albendazole - therapeutic use Animals Anthelmintics - therapeutic use Clinical Protocols Combined Modality Therapy - methods Combined Modality Therapy - mortality Cysts - parasitology Cysts - therapy Drug Therapy, Combination Echinococcosis - mortality Echinococcosis - therapy Female Humans Longitudinal Studies Male Middle Aged Praziquantel - therapeutic use Retrospective Studies Spain - epidemiology Treatment Outcome Watchful Waiting |
title | Management of cystic echinococcosis in the last two decades: what have we learned? |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T11%3A42%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Management%20of%20cystic%20echinococcosis%20in%20the%20last%20two%20decades:%20what%20have%20we%20learned?&rft.jtitle=Transactions%20of%20the%20Royal%20Society%20of%20Tropical%20Medicine%20and%20Hygiene&rft.au=Velasco-Tirado,%20Virginia&rft.date=2018-05-01&rft.volume=112&rft.issue=5&rft.spage=207&rft.epage=215&rft.pages=207-215&rft.issn=0035-9203&rft.eissn=1878-3503&rft_id=info:doi/10.1093/trstmh/try050&rft_dat=%3Cproquest_cross%3E2054942522%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2054942522&rft_id=info:pmid/29897552&rfr_iscdi=true |